1076 - 1100 of 6420 Results
Title
Year
-
OPENTitle: Development of a multiplexed targeted mass spectrometry assay for LRRK2-phosphorylated Rabs and Ser910/Ser935 biomarker sitesJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 478Issue #: 2Start Page: 299End Page: 326Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1042/bcj20200930Best OA location URL: https://portlandpress.com/biochemj/article-pdf/478/2/299/902526/bcj-2020-0930.pdfCitation Count: 43
-
OPENTitle: Microdroplet-based one-step RT-PCR for ultrahigh throughput single-cell multiplex gene expression analysis and rare cell detectionJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-021-86087-4Best OA location URL: https://www.nature.com/articles/s41598-021-86087-4.pdfCitation Count: 24
-
OPENTitle: Validation of a Parkinson Disease Predictive Model in a Population-Based StudyJournal Name: Parkinson's DiseasePublisher: WileyVol: 2020Issue #:Start Page: 1End Page: 7Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2020/2857608Best OA location URL: https://downloads.hindawi.com/journals/pd/2020/2857608.pdfCitation Count: 10
- Shared proteomic effects of cerebral atherosclerosis and Alzheimer’s disease on the human brain2020OPENTitle: Shared proteomic effects of cerebral atherosclerosis and Alzheimer’s disease on the human brainJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 23Issue #: 6Start Page: 696End Page: 700Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41593-020-0635-5Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7269838Citation Count: 136
- Stress cardiomyopathy associated with the first manifestation of multiple sclerosis: a case report2020OPENTitle: Stress cardiomyopathy associated with the first manifestation of multiple sclerosis: a case reportJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 20Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-020-01757-6Best OA location URL: https://bmcneurol.biomedcentral.com/track/pdf/10.1186/s12883-020-01757-6Citation Count: 8
- Extent of N-terminus exposure of monomeric alpha-synuclein determines its aggregation propensity2020OPENTitle: Extent of N-terminus exposure of monomeric alpha-synuclein determines its aggregation propensityJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41467-020-16564-3Best OA location URL: https://www.nature.com/articles/s41467-020-16564-3.pdfCitation Count: 140
- Capgras Delusion in Posterior Cortical Atrophy–A Quantitative Multimodal Imaging Single Case Study2020OPENTitle: Capgras Delusion in Posterior Cortical Atrophy–A Quantitative Multimodal Imaging Single Case StudyJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2020.00133Best OA location URL: https://doi.org/10.3389/fnagi.2020.00133Citation Count: 6
-
OPENTitle: Association Between Cerebrospinal Fluid Biomarkers and Age-related Brain Changes in Patients with Normal Pressure HydrocephalusJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-020-66154-yBest OA location URL: https://www.nature.com/articles/s41598-020-66154-y.pdfCitation Count: 18
-
OPENTitle: The GTPase Rab27b regulates the release, autophagic clearance, and toxicity of α-synucleinJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 295Issue #: 23Start Page: 8005End Page: 8016Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1074/jbc.ra120.013337Best OA location URL: http://www.jbc.org/article/S0021925817494397/pdfCitation Count: 28
-
OPENTitle: Witnessed apneas are associated with elevated tau-PET levels in cognitively unimpaired elderlyJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 17Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000009315Best OA location URL: https://n.neurology.org/content/neurology/94/17/e1793.full.pdfCitation Count: 37
-
OPENTitle: Faster disease progression in Parkinson’s disease with type 2 diabetes is not associated with increased α‐synuclein, tau, amyloid‐β or vascular pathologyJournal Name: Neuropathology and Applied NeurobiologyPublisher: WileyVol: 47Issue #: 7Start Page: 1080End Page: 1091Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/nan.12728Citation Count: 30
-
OPENTitle: A novel systems biology approach to evaluate mouse models of late-onset Alzheimer’s diseaseJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-020-00412-5Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-020-00412-5Citation Count: 52
-
OPENTitle: Disease modifying treatment trials in Parkinson’s disease: how to balance expectations and interests of patients, physicians and industry partners?Journal Name: Neurological Research and PracticePublisher: Springer Science and Business Media LLCVol: 2Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s42466-020-00076-yBest OA location URL: https://neurolrespract.biomedcentral.com/track/pdf/10.1186/s42466-020-00076-yCitation Count: 3
-
OPENTitle: A machine learning-based classification approach on Parkinson’s disease diffusion tensor imaging datasetsJournal Name: Neurological Research and PracticePublisher: Springer Science and Business Media LLCVol: 2Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s42466-020-00092-yBest OA location URL: https://neurolrespract.biomedcentral.com/track/pdf/10.1186/s42466-020-00092-yCitation Count: 29
-
OPENTitle: Quantitative Measurements of LRRK2 in Human Cerebrospinal Fluid Demonstrates Increased Levels in G2019S PatientsJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2020.00526Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2020.00526/pdfCitation Count: 29
-
OPENTitle: Telephone-based cognitive behavioral therapy for depression in Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 16Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/wnl.0000000000009292Best OA location URL: https://n.neurology.org/content/neurology/94/16/e1764.full.pdfCitation Count: 107
- Metabolic syndrome does not influence the phenotype of LRRK2 and GBA related Parkinson’s disease2020OPENTitle: Metabolic syndrome does not influence the phenotype of LRRK2 and GBA related Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-020-66319-9Best OA location URL: https://www.nature.com/articles/s41598-020-66319-9.pdfCitation Count: 21
-
OPENTitle: Mitofusin 2 displays fusion-independent roles in proteostasis surveillanceJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 16Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-025-56673-5Best OA location URL: https://doi.org/10.1038/s41467-025-56673-5Citation Count: 0
-
OPENTitle: Patient-centered brain transcriptomic and multimodal imaging determinants of clinical progression, physical activity, and treatment needs in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41531-025-00878-4Best OA location URL: https://doi.org/10.1038/s41531-025-00878-4Citation Count: 0
-
OPENTitle: A proteome-wide quantitative platform for nanoscale spatially resolved extraction of membrane proteins into native nanodiscsJournal Name: Nature MethodsPublisher: Springer Science and Business Media LLCVol: 22Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41592-024-02517-xBest OA location URL: https://doi.org/10.1038/s41592-024-02517-xCitation Count: 1
-
OPENTitle: DOPA pheomelanin is increased in nigral neuromelanin of Parkinson’s diseaseJournal Name: Progress in NeurobiologyPublisher: Elsevier BVVol: 223Issue #:Start Page: 102414End Page: 102414Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.pneurobio.2023.102414Best OA location URL: https://doi.org/10.1016/j.pneurobio.2023.102414Citation Count: 12
-
OPENTitle: Ethnoracial differences for caregiving burden in Parkinson’s diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 118Issue #:Start Page: 105927End Page: 105927Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105927Best OA location URL: http://www.prd-journal.com/article/S1353802023010064/pdfCitation Count: 1
- Excessive Daytime Sleepiness as a Risk Factor for Impulse Control Disorders in Parkinson’s Disease2024OPENTitle: Excessive Daytime Sleepiness as a Risk Factor for Impulse Control Disorders in Parkinson’s DiseaseJournal Name: Neuropsychiatric Disease and TreatmentPublisher: Informa UK LimitedVol: Volume 20Issue #:Start Page: 2517End Page: 2527Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.2147/ndt.s485339Best OA location URL: https://doi.org/10.2147/ndt.s485339Citation Count: 1
-
OPENTitle: Tagless LysoIP for immunoaffinity enrichment of native lysosomes from clinical samplesJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 135Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1172/jci183592Best OA location URL: http://www.jci.org/articles/view/183592/files/pdfCitation Count: 2
-
OPENTitle: Brain age in genetic and idiopathic Parkinson's diseaseJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 6Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcae382Best OA location URL: https://doi.org/10.1093/braincomms/fcae382Citation Count: 2